Thompson Davis & Co., Inc. Endra Life Sciences Inc. Transaction History

Thompson Davis & Co., Inc.

  • $132 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.69 - $1.73 $4,174 - $10,466
-6,050 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$1.94 - $3.57 $11,737 - $21,598
6,050 New
6,050 $19,000

About ENDRA Life Sciences Inc.

NDRA Quotes by TradingView
  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $398M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track Thompson Davis & Co., Inc. Portfolio

Follow Thompson Davis & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email